TP Therapeutics is a structure-based drug design company for the discovery and development of precision medicines for cancer. The company was founded on October 2013 based on research conducted by Jean Cui, TP’s Founder and Chief Scientific Officer and is focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations. TP Therapeutics is headquartered in San Diego, California.